Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

redsoxwin20042004 3 posts  |  Last Activity: May 13, 2015 10:13 AM Member since: Mar 31, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Is 661 part of the multi drug cocktail?

    by fer01mat Mar 23, 2015 11:53 AM
    redsoxwin20042004 redsoxwin20042004 Mar 23, 2015 5:03 PM Flag

    Verty's got it right (been lurking). - most won't see the positive in this release but that's not my problem & VRTX management shouldn't care either. Remember...to a CF patient or parent...all we want is to arrest the disease; To [theoretically] stop the lung related affects of CF in its tracks. Which, for a growing # of CF-ers, is what VRTX science delivers. Trust me...if I could halt my kids lung function at 87%...I'd take it and RUN! The only other option is to watch these patients is to get sicker and sicker by the day - right before your eyes. Last part of my rant...VRTX has the corrector/potentiator market until at least 2022 and IMO, once K + Lumacaftor revenues come in, they will be active buyers.

    Sentiment: Buy

  • Reply to

    feuerstein s coverage

    by verityvoila May 13, 2015 7:13 AM
    redsoxwin20042004 redsoxwin20042004 May 13, 2015 9:57 AM Flag

    A historic day and the patient testimonies drove home why Orkambi is getting approved. Kudos to so many.

  • Reply to

    feuerstein s coverage

    by verityvoila May 13, 2015 7:13 AM
    redsoxwin20042004 redsoxwin20042004 May 13, 2015 10:13 AM Flag

    We do too. Hang tight. That data is going to be fine.

VRTX
125.08+0.03(+0.02%)May 22 4:00 PMEDT